DOCSLIB.ORG

Annual Report 2017/2018 Annual Report Agrf 2017/2018 2

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annual Report 2017/2018 Annual Report Agrf 2017/2018 2 ANNUAL REPORT 2017/2018 ANNUAL REPORT AGRF 2017/2018 2 AGRF IMPROVES QUALITY OF LIFE THROUGH EXCEPTIONAL LIFE SCIENCE. AGRF is a not-for-profit organisation, committed to quality and innovation. We actively seek to partner and share our knowledge and expertise in genomics. Through our national network, AGRF provides access to innovative and leading technologies, enabling genomics in the biomedical, agricultural and environmental domains. From single gene analysis to whole genome sequencing, AGRF provides a full range of genomic capabilities and services with complementary bioinformatics across the entire biological spectrum, to academia, healthcare and commercial industries. www.agrf.org.au ABN 63 097 086 292 © Australian Genome Research Facility Ltd 2018. ANNUAL REPORT AGRF 2017/2018 3 CONTENTS Chairman’s Message & A Word from our CEO 04-05 Our Vision, Mission & Values 06-07 Our Team 08-09 Spotlight - Chris Noune and Microbiome 10-11 The Genetics of Epilepsy 12-13 A Key Partner 14-15 Spotlight - Our Clinical Team 16-17 Zero Childhood Cancer 18-19 About Our Clients 20-21 Celebrating 20 Years of AGRF 22-25 Leading Through Innovation 26-27 Single Cell Analysis of Breast Cancer 28-29 Events & Engagement 30-31 Overcoming Anxiety 32-33 Black Tiger Shrimp Transcriptome 34 Our Bioinformatics Team 35 Proudly Supporting Academic Research 36-37 Publications 38-39 Our Board of Directors 40-41 Our Executive Team & Our Funding Partners 42-43 ANNUAL REPORT AGRF 2017/2018 4 CHAIRMAN’S MESSAGE In 2017/2018 AGRF continued to deliver on our mission of providing “national quality state-of-the-art genomic services to Australia’s researchers and industry”. AGRF maintains Australia’s most comprehensive and distributed array of genomic platforms and capabilities to meet the diversified needs of the biomedical, agricultural, and environmental research and industry domains. AGRF’s transformation strategy continued in 2017/2018 to ensure we are positioned to meet the needs of the Australian genomics community. The key initiative in this context was the relocation of AGRF’s Melbourne laboratories to the Victorian Comprehensive Cancer Centre (VCCC) and engaging with the pathology community in developing solutions to the future needs of Australian clinical genomics. Of particular significance in 2017/2018 was our achievement of ISO15189 Accreditation for Medical Testing Laboratories. With over 20 years of genomics expertise, AGRF now delivers NATA accredited workflows for clinical genomic applications, including genome-wide genotyping, Whole Exome Sequencing, and Sanger sequencing. In 2017/2018, we moved into the second year of our growth strategy with critical initiatives to underpin all aspects of AGRF’s growth, culture, diversification of platforms and services, promotion, and governance. This included the welcoming of new leadership and operational staff in critical areas of Business & Market Development, Research Partnerships, and Science & Technology, as well AGRF’s operational areas of People & Culture, Laboratory Services, and Finance & Business Services. It is exciting to see throughout this report, the It is pleasing to report the 2017/2018 financial diverse work that AGRF has supported throughout year again delivered a positive result with both this financial year, particularly across the research revenues and EBITA above budget. The credit areas of Epilepsy, Childhood Cancer, Mental Health, for this is due to the AGRF management and staff Breast Cancer, and Aquaculture. We are proud to who continued to deliver the most commendable support our clients across all disciplines and look dedication and persistence in response to the forward to working with them again in 2018/2019. complex challenges of increasing competition, restraints and uncertainties in government 2018/2019 will no doubt be an exciting year. The funding and continued technological advances. transitioning initiatives of the past year have primed AGRF for the transformation and growth vision I thank my fellow Board Directors for their and agenda we have set. The AGRF Board looks continued unstinting contribution and enthusiasm forward to working with management, staff and our to AGRF’s mission and continuing success. research and industry clients and collaborators in this pursuit, with the aim of providing Australia’s The continuing contribution of Bioplatforms leading genomics solutions across the biomedical, Australia (BPA) to many of AGRF’s activities is also agricultural and environmental domains. acknowledged and greatly appreciated. ANNUAL REPORT AGRF 2017/2018 5 A WORD FROM OUR CEO 2017/2018 was an important year for AGRF as we implemented our five-year strategy to “grow through transformation”. Our move to the VCCC allowed us to co-locate our Melbourne teams in support of our ‘One AGRF’ culture. With clever design and attention to detail we have created an environment promoting engagement, collaboration, and creative thinking, all of which is supported by the wonderful space and natural light offered on level 13. The move to the VCCC allows AGRF to continue our strategic imperative of leading, enabling, and supporting clinical genomics as a key partner. Beyond clinical genomics and biomedical activity, AGRF also supports agricultural and environmental genomics. This includes improvements to livestock and crops, right through to monitoring our environment. Early access to technology is increasingly becoming a source of competitive advantage for researchers globally. In 2016, we recognised the importance of this, and founded the Genomics Innovation Hub (GIH), in partnership with the University of Melbourne, the Peter MacCallum Cancer Centre, the Walter and Eliza Hall Institute, the Murdoch Children’s Research Institute, and BioPlatforms Australia. In the past year, the GIH has completed a number of projects in collaboration with Our clinically accredited services include researchers, including the exciting area of Whole Exome Sequencing, Single Nucleotide single cell genomics, with work recently Polymorphism Array Genotyping, and Sanger published in Nature Medicine by Professor Sequencing. We are also in the final stages of Sherene Loi, Medical Oncologist at the VCCC. securing accreditation for our Whole Genome Sequencing services. Our clinically accredited In May 2018, the Federal government expertise combined with in-house bioinformatics announced a $500M investment through the and curation capability allows AGRF to be a Australian Genomics Health Futures Mission, key partner in clinical genomics. This is further to “help save or transform the lives of more supported by our active memberships and than 200,000 Australians through research partnerships with the Australian, Melbourne and into better testing, diagnosis and treatment”. Queensland Genomic Health Alliances, where AGRF is excited to support this national AGRF has been involved in a number of key agenda. projects. Furthermore, as part of our strategic “growth I take this opportunity to express my gratitude to through transformation” vision, AGRF has our supporters and partners who have entrusted secured ISO15189 Clinical Accreditation for us with their projects, and have allowed us to Medical Testing. This is a great opportunity continue to deliver genomics expertise for over for us to continue to expand our offerings to 20 years. I would also like to thank our AGRF include clinical-grade genomics services in staff for their contributions and dedication over our expanding portfolio. the year. ANNUAL REPORT AGRF 2017/2018 6 OUR VISION To be a key enabler of world-class genomic science. OUR VALUES innovation integrity respect We embrace genomic We always act in the We honour challenges with best interests of our individuality and curiosity, novel stakeholders and appreciate our approaches and AGRF as a whole. working relationships. world class technologies. Putting our valued staff in the spotlight AGRF launched a staff Recognition Awards Program in February 2018 which provides an opportunity to ‘shine the spotlight’ on an individual, team or group of people for their work that is aligned with our Values in Practice. ANNUAL REPORT AGRF 2017/2018 7 OUR MISSION To provide Australia with a world standard, research integrated capability, delivering genomic solutions to the biomedical, agricultural, and environmental sectors to address key scientific questions. excellence client focused collaboration & teamwork We are proud of our We are committed to We build inclusive quest to be delivering exceptional and valued outstanding in services, all of the relationships in everything we do. time. pursuit of shared goals. Our new AGRF Recognition Awards Program aligns AGRF’s Values in Practice to the nomination criteria. Launching this program is part of the 2017 – 2022 strategic goal: to collectively promote and foster a high performing ‘One AGRF’ culture, and an environment where achievements and contributions are noticed, appreciated and celebrated. ANNUAL REPORT AGRF 2017/2018 8 15 58% languages spoken by staff with our staff parents not born in Australia 36% staff not born in Australia DIVERSITY DRIVING INNOVATION We employ more than 70 highly skilled staff, with a broad range of skills and diverse backgrounds. We wanted to highlight that diversity here. 11% Baby Boomers 32% Generation X 57% Generation Y born 1946-1964 born 1965 - 1979 born 1980 - 1994 ANNUAL REPORT AGRF 2017/2018 9 OUR NATIONAL NETWORK Our Melbourne Team Our Brisbane Team Our Perth Team Our Sydney Team Our Adelaide Team ANNUAL REPORT AGRF 2017/2018
Load more

Recommended publications
  • Cortical Connections 2015
    Cortical Connections 2015 19th and 20th of March, 2015 Queensland Brain Institute Brisbane, Australia Program, Speaker Biographies, and Abstracts Programme Day 1 Thursday March 19 Programme Day 1 Thursday March 19 8:15AM Registration open Session 2: Genetics of cortical wiring disorders 8:45AM Welcome by Prof. Linda Richards Queensland Brain Institute 12:00– Prof. Elliott Sherr 1:00PM University of California, San Francisco Cerebral connectivity: from genes to cognition Session 1: Development of cortical wiring 1:00– Lunch at QBI 9:00– Prof. Roberto Lent 1:30PM 10:00AM Federal University of Rio de Janeiro 1:30– Distance plasticity - on connectomes Prof. Jozef Gécz 2:00PM University of Adelaide and dysconnectomes Protocadherin 19 and female limited 10:00– Dr Richard Leventer epilepsy and intellectual disability Session chairs 10:30AM Dr Jens Bunt Murdoch Childrens Research Institute, Melbourne 2:00– Agenesis of the corpus callosum and the Prof. Kathryn North and 2:30PM Director, Murdoch Childrens Research Institute, company it keeps Dr Peter Kozulin Session chairs Melbourne 10:30– Dr Ilan Gobius Learning disabilities in childhood – lessons from Prof. Stephen Williams and 11:00 AM Queensland Brain Institute Ms Laura Fenlon Active dendritic integration underlies circuit- 2:30– based neocortical computations Prof. Ingrid Scheffer 3:00PM The University of Melbourne, Florey Neurosciences 11:00 – Institute, Murdoch Childrens Research Institute, 11:30 AM Morning tea on the QBI terrace Melbourne Genetics of the epilepsies—framing cortical 11:30 AM– Prof. Linda Richards connections 12:00PM Queensland Brain Institute Development of the corpus callosum 3:00– 3:30PM Afternoon tea 3:30– Prof.
    [Show full text]
  • Paediatric Epilepsy Research Report 2019
    Paediatric Epilepsy 2019 Research Report Inside Who we are The organisations and experts behind our research programme What we do Our strategy, projects and impact youngepilepsy.org.uk Contents Introduction 1 Who we are 2 Research Partners 2 Research Funding 4 Research Team 5 What we do 10 Programme Strategy 10 The MEG Project 12 New Research Projects 14 Research Project Update 21 Completed Projects 32 Awarded PhDs 36 Paediatric Epilepsy Masterclass 2018 37 Paediatric Epilepsy Research Retreat 2019 38 Research Publications 40 Unit Roles 47 Unit Roles in Education 49 Professional Recognition and Awards 50 Paediatric Epilepsy Research Report 2019 Introduction I am delighted to present our annual research report for the period July 2018 to June 2019 for the paediatric epilepsy research unit across Young Epilepsy, UCL GOS - Institute of Child Health and Great Ormond Street Hospital for Children. We have initiated 13 new research projects, adding to 20 active projects spanning the clinical, educational and social elements of paediatric epilepsy. We have published 110 peer-reviewed items of primary research and a further 54 chapters in books, reviews and commentaries of expert opinion. During this period, Young Epilepsy Chief Executive Carol Long caught the research bug and moved on to begin her PhD at Durham University. We welcomed our new Chief Executive, Mark Devlin at our Paediatric Epilepsy Research Retreat in January 2019. As an organisation, we are launching a new strategy This report features a spotlight on a truly which sets our research programme as one of innovative project which will change the UK’s the four key offers at Young Epilepsy, and we diagnostic and surgical evaluation imaging suite look forward to sharing our research more widely for childhood epilepsy.
    [Show full text]
  • 2016 Annual Review a Summary of Our Year
    2016 Annual Review A summary of our year Royal Society Te Apārangi 0 Contents Introduction from the President ............................................................................................................... 2 Explore ........................................................................................................................................................... 3 Increased funding allowed Marsden Fund to support more early-career researchers ............................. 3 Supporting established researchers to explore their area of expertise .................................................... 3 Supporting early career researchers to become leaders .......................................................................... 4 Supporting emerging researchers to develop their careers ...................................................................... 4 ORCID Consortium will help close the loop on New Zealand’s research system ....................................... 5 Powering Potential on climate change ...................................................................................................... 6 NZIFST/CREST Student Product Development Challenge .......................................................................... 6 Teachers in Industry .................................................................................................................................. 6 Science Teaching Leadership Programme ................................................................................................
    [Show full text]
  • Melbourne Neuroscience Institute 2017 Annual Report
    Melbourne Neuroscience Institute 2017 Annual Report A © The Melbourne Neuroscience Institute Enquiries for reprinting information contained in this publication should be made through: [email protected] Every attempt has been made to ensure that the information in this publication was correct at the time of printing. Editor: Amy Bugeja Designer: External Relations 23201 For further information visit: www.neuroscience.unimelb.edu.au Contents Executive Summaries 02 Research 04 Engagement 32 Partnerships 45 Funding Initiatives 50 Governance 54 1 CHAPTER 1 Executive Summaries Message from the Director It is with great pleasure that we table the 2017 annual report for the Melbourne Neuroscience Institute (MNI). The MNI has now been extant for 8 years and during that time it has unwaveringly served to promote the Neurosciences and related disciplines at the University of Melbourne. This report serves to demonstrate both the current strength of Neuroscience research on campus and the role that MNI has played in fostering many of these activities. The spectrum of Neuroscience research conducted at this University is impressive and what is presented in this report is an important but, by necessity, a small proportion of the exciting work that is being conducted. What is very apparent is that much of the work relies on strong collaborative interactions and often those collaborative interactions span several faculties. I am particularly pleased to see this, reflecting that the promotion of Our international interface continues to strengthen. This is most interdisciplinarity that has been one of the key goals of MNI, apparent through our strong links with the Salpetriere in Paris and an outcome that we have been able to facilitate via our with the Hotchkiss Brain Institute in Calgary.
    [Show full text]
  • Classification of the Epilepsies and to Solicit Tion Framework Proves Incompatible with New Findings, We Comments and Criticism from Readers
    SPECIAL REPORT Classification of the epilepsies: New concepts for discussion and debate—Special report of the ILAE Classification Task Force of the Commission for Classification and Terminology1 *†‡Ingrid E. Scheffer, §Jacqueline French, ¶#Edouard Hirsch, **Satish Jain, ††Gary W. Mathern, ‡‡Solomon L Moshe, §§Emilio Perucca, ¶¶Torbjorn Tomson, ##Samuel Wiebe, ***Yue-Hua Zhang, and †††‡‡‡Sameer M. Zuberi Epilepsia Open, 1(1):37–44, 2016 doi: 10.1002/epi4.5 SUMMARY The ILAE Task Force on Classification presents a road map for the development of an updated, relevant classification of the epilepsies. Our objective is to explain the pro- cess to date and the plan moving forward as well as to invite further discussion about the newly proposed terms and concepts. Here, we present our response to feedback about the 2010 Organization of the Epilepsies and clarify the reintroduction of the word “classification” to map out a framework for epilepsy diagnosis. We introduce some new concepts and suggest four diagnostic levels: seizure type, epilepsy category, epilepsy syndrome, and epilepsy with (specific) etiology to denote specific levels of diagnosis. We expand the etiological categories to six, focusing on those with treat- ment implications. Finally, we discuss the changes in terminology originally suggested Prof Ingrid Scheffer and modifications in response to comments from the epilepsy community. We wel- chairs the ILAE Task come feedback and discussion from the global epilepsy community, particularly for the Force on the new suggested terms, so that we can cement a classification that both reflects current Classification of the thinking and scientific understanding and provides a dynamic, evolving framework. Epilepsies.
    [Show full text]
  • Newsletter ISSUE NUMBER 4 2005 PILEPSY ESEARCH E R Elcome to the 2005 Edition of the Experience from Their Countries, and We C ENTRE Wepilepsy Genetics Newsletter
    EPILEPSY GENETICS Newsletter ISSUE NUMBER 4 2005 PILEPSY ESEARCH E R elcome to the 2005 edition of the experience from their countries, and we C ENTRE WEpilepsy Genetics Newsletter. We all benefit enormously from the Austin Health like to keep you informed of all our excit- opportunity to exchange ideas. Heidelberg Repatriation Hospital, ing developments from our last year of Sadly, during 2004 we said farewell to Banksia Street,West Heidelberg, hard work here at the Epilepsy Research Centre at Austin Health,Melbourne and the several members of our team. Dr Lata Victoria 3081 University of Melbourne. We also take this Vadlamudi moved to become an academic Tel: (03) 9496 2737 opportunity to thank all of our five and a neurologist in Canberra where she will Fax: (03) 9496 2291 half thousand research participants and complete her PhD thesis, and Dr Nigel Tan Email: [email protected] supporters for their time and energy in returned to Singapore after spending 18 Website: www.epilepsyresearch.org.au helping our research to continue. Without months with us. We hope to keep working their kind assistance and enthusiastic closely with both Dr Vadlamudi and Dr Tan attitude to the research, our continuing in the coming years. Two research success and progress in the field would assistants, Sarah McInnes and Deborah not be possible. Keay (Glencross), also left the team during 2004. The research team, headed by Professor Sam Berkovic and Associate Professor Our work in the area of the genetics Ingrid Scheffer, is now in its 16th year and of epilepsy continues to progress well we continue striving to unravel the with a number of important scientific Professor Samuel Berkovic inheritance of seizures in both families and publications throughout the year.
    [Show full text]
  • Life As a Clinician-Scientist
    2021 VICTORIAN SYMPOSIUM Life as a Clinician-Scientist Saturday 31 July Monash University About the Academy The Australian Academy of Health and Medical Sciences is the impartial, authoritative, cross-sector voice of health and medical science in Australia. We are an independent, interdisciplinary body of 425 Fellows – elected by their peers for their distinguished achievements and exceptional contributions to health and medical science in Australia. Collectively, they are a representative and independent voice, through which we engage with the community, industry and governments. The Academy is uniquely positioned to convene cross-sector stakeholders from across Australia to address the most pressing health challenges facing society. We focus on the development of future generations of health and medical researchers, on providing independent advice to government and others on issues relating to evidence based medical practice and medical researchers, and on providing a forum for discussion on progress in medical research with an emphasis on translation of research into practice. The Academy is registered with the Australian Charities and Not-for-profits Commission (ACNC) and in endorsed as a deductible gift recipient. www.aahms.org @MedSciAcademy @AAHMS_Health Welcome to Life as a Clinician-Scientist Today we welcome you to showcase Life as a Clinician-Scientist. Our speakers will share their unique journeys that have led to a rich and rewarding career, filled with challenge and discovery. Why consider life as a clinician-scientist? Clinician-scientists have a unique and irreplaceable set of skills, enabling them to marry key clinical questions with insights into human biology. Medicine integrated with science allows you to take clinical observations and curiosities from the bedside, to answer deeper scientific questions, and translate these to have far reaching impact on improving patients’ lives.
    [Show full text]
  • Variable Clinical and Molecular Expressivity of PCDH19 Variants and Girls Clustering Epilepsy
    Variable Clinical and Molecular Expressivity of PCDH19 Variants and Girls Clustering Epilepsy A disorder of cellular “mosaics” Thesis submitted for the degree of Doctor of Philosophy by Kristy Louise Kolc BSc-Psychology (Hons) April 2020 School of Population Health Faculty of Health Sciences The University of Adelaide, Australia University of Adelaide Adelaide Medical School, Faculty of HealthAustralia and Medical Sciences Children see magic because they look for it - Christopher Moore Science is nothing but perception. - Plato Title Variable Clinical and Molecular Expressivity of PCDH19 Variants and Girls Clustering Epilepsy: A disorder of cellular “mosaics” Author Kristy Kolc Institute Adelaide Medical School Academic advisors Professor Jozef Gecz, Adelaide Medical School A/Prof Rachel Roberts, School of Psychology Dr Duyen Pham, Adelaide Medical School Dr Raman Kumar, Adelaide Medical School Adelaide Medical School University of Adelaide Adelaide Health and Medical Sciences Building ADELAIDE SA 5000 E-mail: [email protected] webpage: https://health.adelaide.edu.au/medicine/ TABLE OF CONTENTS TABLE OF CONTENTS TABLE OF CONTENTS .............................................................................................................. i LIST OF TABLES ....................................................................................................................... v LIST OF FIGURES .................................................................................................................... vi LIST OF ABBREVIATIONS
    [Show full text]
  • Paediatric Epilepsy Research Report 2020
    Paediatric Epilepsy 2020 Research Report Inside Who we are The organisations and experts behind our research What we do Our strategy, projects and impact youngepilepsy.org.uk Contents Introduction 1 Who We Are 2 Research Partners 2 What We Do 4 Research Strategy 4 Research Impact 7 Past Impact 8 Current Impact 10 What’s Next 12 Research Projects 13 New Projects 14 Ongoing Projects 22 Completed Projects 37 Research Funding 42 Further Activities 43 E-CURe Network Launch 43 Young Epilepsy Research Retreat 2020 44 Collaborative Awards 45 Research Team 46 Congratulations 51 Research Publications 52 Glossary 57 Paediatric Epilepsy Research Report 2020 Introduction I am delighted to present our annual research report for the period July 2019 to June 2020 for the paediatric epilepsy research partnership across Young Epilepsy, UCL GOS - Institute of Child Health and Great Ormond Street Hospital for Children. During this period, we have initiated 15 new research projects, adding to 30 active projects spanning the clinical, educational and social elements of paediatric epilepsy. We have published 62 peer-reviewed items of primary research, 28 reviews and a further 5 chapters in books. We continue to share expertise with research and clinical colleagues and in January 2020 held our 10th International Paediatric Epilepsy Research Retreat for researchers and collaborators across the unit. This meeting was a wonderful celebration of the work of the unit over the past decade. We enjoyed record attendance as well as welcoming two eminent Research Moderators; Professor Alexis Arzimanoglou of University Hospitals of Lyon, and Professor Mathias Koepp of even greater still, the changes to all lives and pursuits UCL Queen Square Institute of Neurology.
    [Show full text]
  • “La Genomica in Sanità Pubblica: Attualità E Futuro”
    Curricula RELATORI M. 0701-08 Rev. 00 del 07/04/2014 Silvia De Rubeis E-mail [email protected] Date of birth 03/05/1982 Work address Dept. Psychiatry, Icahn School of Medicine at Mount Sinai Home address 68 E 97th street apt 24, New York, 10029 NY Phone +1-212-241-0241 Nationality italian Research experience 03/2013-present Seaver postdoctoral fellow Dept. Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA Dr. Joseph D. Buxbaum 01/2010-12/2012 Postdoctoral fellow Center for Human Genetics, Katholieke Universiteit Leuven, Belgium Dr. Claudia Bagni 03-04/2010 EMBO short-term postdoctoral fellow Center for Neural Science, New York University, New York, USA Dr. Eric Klann Education 2006-2009 PhD in Cellular and Molecular Biology University of Rome ‘Tor Vergata’, Rome, Italy Dr. Claudia Bagni 2004-2006 Master bachelor in Cellular and Molecular Biology University of Rome ‘Tor Vergata’, Rome, Italy Dr. Claudia Bagni 2001-2004 Bachelor in Molecular and Cellular Biology University of Rome ‘Tor Vergata’, Rome, Italy Dr. Patrizia M. Baldini Publications 1. Ionita-Laza I, Capanu M, De Rubeis S, McCallum J, Buxbaum JD. Identification of rare causal variants in sequence-based studies: methods and applications to gene VPS13B, involved in Cohen syndrome and autism. PLoS Genetics, 10(12):e1004729 2. De Rubeis S, He X, Goldberg AP, Poultney CP, et al. Synaptic, chromatin and transcriptional genes disrupted in autism. Nature, 515(7526), 209-15 3. Braat S, D’Hulst C, Heulens I, De Rubeis S, Mientjes E, Nelson DL, Willemsen R, Bagni C, Van Dam D, De Deyn PP, Kooy RF.
    [Show full text]
  • Download the Trustees' Report and Financial Statements 2018-2019
    Science is Global Trustees’ report and financial statements for the year ended 31 March 2019 The Royal Society’s fundamental purpose, reflected in its founding Charters of the 1660s, is to recognise, promote, and support excellence in science and to encourage the development and use of science for the benefit of humanity. The Society is a self-governing Fellowship of distinguished scientists drawn from all areas of science, technology, engineering, mathematics and medicine. The Society has played a part in some of the most fundamental, significant, and life-changing discoveries in scientific history and Royal Society scientists – our Fellows and those people we fund – continue to make outstanding contributions to science and help to shape the world we live in. Discover more online at: royalsociety.org BELGIUM AUSTRIA 3 1 NETHERLANDS GERMANY 5 12 CZECH REPUBLIC SWITZERLAND 3 2 CANADA POLAND 8 1 Charity Case study: Africa As a registered charity, the Royal Society Professor Cheikh Bécaye Gaye FRANCE undertakes a range of activities that from Cheikh Anta Diop University 25 provide public benefit either directly or in Senegal, Professor Daniel Olago from the University of indirectly. These include providing financial SPAIN UNITED STATES Nairobi in Kenya, Dr Michael OF AMERICA 18 support for scientists at various stages Owor from Makerere University of their careers, funding programmes 33 in Uganda and Professor Richard that advance understanding of our world, Taylor from University College organising scientific conferences to foster London are working on ways to discussion and collaboration, and publishing sustain low-cost, urban water supply and sanitation systems scientific journals.
    [Show full text]
  • Perception, Imagination and Change
    Epilepsy Perception, imagination and change Medical History Museum, University of Melbourne Epilepsy is one of the most common neurological conditions, affecting one in 26 people during their lifetime. Despite its prevalence, epilepsy has long been misunderstood, immersed in superstition, fear and prejudice. In the 19th century neurologists began to understand the causes Epilepsy of the disorder, although misleading terms such as ‘the dreamy state’, ‘psychic seizures’ Perception, imagination and change and ‘double consciousness’ prevailed. Even today, fear and misinformation affect the daily lives of many people with this condition. Epilepsy: Perception, imagination and change explores different cultural and historical perspectives on epilepsy, and includes accounts from scientists and physicians whose discoveries are improving the quality of lives of people with epilepsy. Both the book and the exhibition held at the University of Melbourne’s Medical Edited by History Museum in 2014 embrace research Jim Chambliss, Mark Cook and Jacqueline Healy undertaken by Dr Jim Chambliss in collaboration with artists who have epilepsy. Many of their works are reproduced here, accompanied by their own descriptions of their art and its place in their lives. This book increases our understanding and awareness of epilepsy. The history affects our perceptions of the condition, the artwork shows the power of the artists’ imaginations, and the innovative work of leading researchers points to the changes ahead. Medical History Museum, University of Melbourne Published 2014 by the Medical History Museum, Faculty of Contents Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria, 3010, Australia, http://museum.medicine.unimelb.edu.au. © Copyright the authors, the artists or their estates, and the University of Melbourne, 2014.
    [Show full text]